COWEN AND COMPANY, LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$22,539,000
+3.1%
1,100,0000.0%1.58%
-13.0%
Q2 2023$21,857,000
+16.0%
1,100,0000.0%1.81%
-18.1%
Q1 2023$18,843,000
-12.5%
1,100,0000.0%2.21%
-1.7%
Q4 2022$21,527,000
+34.9%
1,100,000
+10.0%
2.25%
+47.5%
Q3 2022$15,953,000
+15.9%
999,588
-0.0%
1.53%
+14.8%
Q2 2022$13,760,000
-13.2%
1,000,0000.0%1.33%
-13.0%
Q1 2022$15,860,000
-27.3%
1,000,0000.0%1.53%
-22.9%
Q4 2021$21,830,000
-27.0%
1,000,0000.0%1.98%
+39.7%
Q3 2021$29,890,000
-32.5%
1,000,0000.0%1.42%
-38.7%
Q2 2021$44,290,0001,000,0002.31%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders